drugset / Trial / NCT01774760
Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer
NaSingle-groupOpen-labelDiagnostic
Summary
The results of previous studies suggest further development of \[18F\]EF5 as a PET tracer for imaging hypoxia. This is a non-randomized prospective study to obtain information on reproducibility of \[18F\]EF5 intratumor distribution using repeated pretreatment PET/CT scans.
Timeline
- Start
- 2013-03
- Primary completion
- 2016-09
- Completion
- 2016-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 18F-EF5 | Diagnostic / imaging agent | 250 mbq | Intravenous |
| Subject | 18F-EF5 | Diagnostic / imaging agent | 350 mbq | Intravenous |